PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

FDA Approves a New Generic Valsartan to Mitigate Shortages

by PEPID Newsroom | Mar 14, 2019 | Alerts

As of March 12, 2019 the U.S. FDA approved a new generic of Diovan (valsartan) for high blood pressure and heart failure to relieve the shortage from multiple recalls of generic valsartan products from several manufacturers. The approval of the new generic of Diovan...

Recent Posts

  • Sepsis in the Emergency Department: Recognition and the First Hours
  • Opioid Use Disorder in the Emergency Department: Buprenorphine Initiation, Naloxone Distribution, and the Warm Handoff on International Overdose Awareness Day
  • Dementia in the Emergency Department: Recognizing Delirium, Anticholinergic Burden, and the “Acting Different” Presentation
  • Heat-Related Illness in the Emergency Department: Recognition, Cooling, and the High-Risk Patient
  • EMS Week in Practice: Strengthening the Prehospital-to-ED Continuum for Better Patient Outcomes

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved